The Use of The Antihistamine Fexafenadine in the Treatment of Children with Seasonal Allergic Rhinitis

dc.contributor.author	Razhabova Iroda Muzaffarovna
dc.contributor.author	Mamutova Peruza Sharafatdinovna
dc.contributor.author	Mamutov Sharafatdin Iskandarovich
dc.date.accessioned	2026-01-02T11:33:17Z
dc.date.issued	2023-09-11
dc.description.abstract	The issues of application and efficacy of III generation antihistamine drug fexofenadine (Telfast) at treatment of seasonal allergic rhinitis in children living in Priaralie region (the Republic of Karakalpakstan) are considered in the article. The main drug of the III generation of antihistamine series fexofenadine is characterized. Fexofenadine is high effective drug which pharmacological effect is realized by blockade of H1-histamine receptors of different tissues and stabilization of membrane of mast cells.
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/4912
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77680
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/4912/4131
dc.source	Eurasian Medical Research Periodical; Vol. 24 (2023): EMRP; 22-24
dc.source	2795-7624
dc.subject	IgE-antibodies
dc.subject	mast cells
dc.subject	eosinophils
dc.subject	interleukins
dc.title	The Use of The Antihistamine Fexafenadine in the Treatment of Children with Seasonal Allergic Rhinitis
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: muzaffarovna_2023_the_use_of_the_antihistamine_fexafenadin.pdf
item.page.filesection.size: 198.62 KB
item.page.filesection.format: Adobe Portable Document Format